Quarterly Summaries
The quarterly summaries provide information on Suspected Adverse Events to veterinary medicines which have been reported to the VMD.
The summaries are for the following periods:
- Quarter 1: 1 January - 31 March
- Quarter 2: 1 April - 30 June
- Quarter 3: 1 July - 30 September
- Quarter 4: 1 October - 31 December
The information is presented in four tables:
- Animal Species Reports - this table represents the breakdown per species of all adverse event reports we have received during each quarter.
- Serious Animal Reports - this table shows the breakdown per species of all serious adverse events received. It looks at all the serious adverse events we received and shows how many were reported to each species.
- Non-Serious Animal Reports - this table shows the breakdown per species of non-serious adverse events received.
- Animal Reports by Product Type - this table represents the breakdown by product type of all adverse event reports we have received during each quarter.
Please note that due to rounding the totals may not add up to 100%.
Select a year:
Animal Species Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 52.9% | 44.7% | 46.6% | 52.4% |
| Cat | 27.5% | 24.3% | 29.1% | 26.2% |
| Cattle | 8.4% | 15.4% | 10.0% | 6.8% |
| Rabbit | 1.9% | 4.1% | 5.2% | 2.0% |
| Horse | 3.2% | 5.4% | 3.7% | 7.1% |
| Sheep | 3.4% | 3.2% | 2.5% | 3.2% |
| Others | 2.7% | 2.9% | 3.0% | 2.4% |
Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 33.9% | 24.7% | 28.7% | 39.7% |
| Cat | 24.1% | 17.7% | 20.7% | 23.0% |
| Cattle | 27.1% | 35.5% | 25.6% | 16.3% |
| Rabbit | 3.8% | 6.2% | 9.4% | 4.7% |
| Horse | 1.4% | 2.2% | 2.0% | 2.7% |
| Sheep | 9.1% | 7.5% | 6.0% | 8.3% |
| Others | 5.9% | 6.2% | 3.0% | 5.3% |
Non-Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 63.8% | 58.0% | 57.5% | 58.8% |
| Cat | 29.4% | 28.7% | 34.1% | 27.9% |
| Cattle | 0.8% | 2.0% | 0.5% | 1.9% |
| Rabbit | 0.8% | 2.7% | 2.6% | 0.7% |
| Horse | 4.2% | 7.5% | 4.7% | 9.4% |
| Sheep | 0.2% | 0.4% | 0.3% | 0.5% |
| Others | 0.8% | 0.7% | 0.2% | 0.9% |
Animal Report by Product Type:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Inactivated vaccine | 12.26% | 18.73% | 15.1% | 10.1% |
| Live vaccine | 18.52% | 15.50% | 19.9% | 17.5% |
| Pain and inflammation | 12.39% | 11.09% | 11.1% | 13.9% |
| Skin parasites | 9.32% | 10.98% | 17.3% | 7.8% |
| Inactivated and live vaccine | 11.62% | 10.66% | 6.9% | 10.1% |
| Bacterial infections | 7.41% | 6.46% | 5.4% | 7.5% |
| Hormone therapy product | 6.77% | 3.66% | 5.3% | 0.5% |
| Miscellaneous | 4.47% | 3.66% | 5.2% | 3.3% |
| Internal parasites | 4.09% | 3.23% | 4.6% | 5.4% |
| Internal and skin parasites | 6.77% | 8.29% | 4.3% | 7.9% |
| Anaesthetics, sedatives and pain killers | 3.38% | 3.44% | 2.4% | 3.3% |
| Heart disease | 1.28% | 2.26% | 2.0% | 1.9% |
| Gastro-intestinal problems | 0.38% | 0.65% | 0.3% | 0.1% |
| Fungal infections | 0.13% | 0.11% | - | 0.3% |
| Coccidial infections | - | - | - | - |
| Dietary supplements | 0.38% | 0.97% | 0.1% | 0.5% |
| Anti Obesity | - | - | - | 0.1% |
| Protozoal infections | 0.38% | - | - | 0.1% |
| Respiratory problems | - | - | - | - |
| Immune system product | - | 0.22% | - | - |
| Topical infections | - | 0.11% | - | 0.1% |
| Anti Neoplastic Agent | - | - | 0.1% | 0.6% |
Animal Species Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 50.1% | 43.5% | 45.2% | 46.1% |
| Cat | 27.4% | 26.0% | 28.5% | 33.4% |
| Cattle | 7.6% | 12.5% | 12.5% | 8.5% |
| Rabbit | 1.3% | 5.4% | 3.1% | 3.3% |
| Horse | 8.2% | 6.7% | 4.8% | 3.9% |
| Sheep | 2.9% | 2.9% | 3.1% | 3.4% |
| Others | 2.6% | 2.9% | 2.6% | 1.3% |
Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 34.4% | 27.2% | 29.2% | 35.47% |
| Cat | 23.1% | 18.5% | 21.7% | 23.31% |
| Cattle | 22.2% | 29.9% | 29.8% | 21.62% |
| Rabbit | 1.9% | 7.1% | 24.7% | 5.41% |
| Horse | 1.9% | 4.3% | 2.2% | 2.03% |
| Sheep | 9.4% | 7.5% | 6.5% | 9.12% |
| Others | 7.1% | 5.5% | 5.9% | 3.04% |
Non-Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 57.0% | 52.5% | 55.4% | 52.1% |
| Cat | 29.2% | 30.1% | 32.8% | 39.1% |
| Cattle | 1.2% | 3.0% | 1.6% | 1.0% |
| Rabbit | 1.0% | 4.5% | 2.2% | 2.1% |
| Horse | 10.9% | 8.0% | 6.5% | 5.0% |
| Sheep | - | 0.4% | 1.0% | 0.2% |
| Others | 0.6% | 1.5% | 0.6% | 0.4% |
Animal Report by Product Type:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Inactivated vaccine | 14.33% | 18.22% | 18.05% | 14.53% |
| Live vaccine | 14.76% | 14.33% | 17.69% | 19.58% |
| Pain and inflammation | 10.74% | 9.46% | 11.91% | 10.47% |
| Skin parasites | 5.16% | 8.48% | 8.90% | 9.11% |
| Inactivated and live vaccine | 16.62% | 11.96% | 11.19% | 9.61% |
| Bacterial infections | 8.60% | 8.07% | 7.58% | 6.40% |
| Hormone therapy product | 5.16% | 5.29% | 8.18% | 6.40% |
| Miscellaneous | 5.44% | 5.01% | 3.25% | 4.31% |
| Internal parasites | 4.30% | 4.87% | 4.81% | 5.30% |
| Internal and skin parasites | 6.45% | 7.09% | 3.85% | 6.90% |
| Anaesthetics, sedatives and pain killers | 5.44% | 5.56% | 2.89% | 3.45% |
| Heart disease | 1.15% | 0.70% | 0.48% | 1.72% |
| Gastro-intestinal problems | 0.72% | 0.56% | 0.36% | 0.86% |
| Fungal infections | 0.14% | 0.14% | - | 0.49% |
| Coccidial infections | - | - | - | 0.12% |
| Dietary supplements | 0.72% | - | 0.48% | 0.12% |
| Anti Obesity | - | - | - | - |
| Protozoal infections | - | - | 0.12% | 0.25% |
| Respiratory problems | - | 0.28% | 0.12% | 0.25% |
| Immune system product | 0.14% | - | 0.12% | - |
| Topical infections | 0.14% | - | - | - |
Animal Species Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 47.0% | 38.8% | 44.2% | 49.9% |
| Cat | 31.4% | 26.8% | 29.1% | 30.8% |
| Cattle | 11.1% | 19.4% | 14.3% | 5.8% |
| Rabbit | 1.4% | 4.9% | 5.3% | 2.8% |
| Horse | 5.0% | 4.3% | 3.4% | 6.2% |
| Sheep | 2.4% | 2.9% | 2.0% | 2.6% |
| Others | 1.7% | 2.8% | 1.7% | 1.9% |
Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 33.0% | 24.9% | 28.2% | 37.9% |
| Cat | 28.3% | 17.2% | 21.1% | 27.2% |
| Cattle | 22.7% | 40.8% | 35.2% | 14.8% |
| Rabbit | 2.6% | 4.9% | 4.9% | 4.7% |
| Horse | 2.6% | 1.9% | 1.8% | 1.2% |
| Sheep | 6.4% | 6.5% | 4.9% | 8.3% |
| Others | 4.3% | 3.9% | 3.9% | 5.9% |
Non-Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 54.6% | 49.5% | 53.6% | 54.5% |
| Cat | 33.1% | 34.2% | 33.7% | 32.1% |
| Cattle | 4.7% | 3.0% | 2.1% | 2.5% |
| Rabbit | 0.7% | 5.0% | 5.6% | 2.0% |
| Horse | 6.4% | 6.2% | 4.3% | 8.0% |
| Sheep | 0.2% | 0.2% | 0.2% | 0.4% |
| Others | 0.2% | 2.0% | 0.4% | 0.4% |
Animal Report by Product Type:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Inactivated vaccine | 12.54% | 20.20% | 21.38% | 15.07% |
| Live vaccine | 15.90% | 15.29% | 17.08% | 15.24% |
| Pain and inflammation | 14.53% | 8.70% | 12.13% | 9.56% |
| Skin parasites | 4.43% | 7.29% | 11.73% | 8.10% |
| Inactivated and live vaccine | 10.70% | 10.38% | 9.26% | 13.45% |
| Bacterial infections | 6.88% | 6.31% | 6.13% | 6.65% |
| Hormone therapy product | 7.65% | 5.75% | 5.48% | 6.48% |
| Miscellaneous | 10.70% | 6.17% | 4.95% | 4.38% |
| Internal parasites | 2.60% | 4.77% | 4.04% | 4.54% |
| Internal and skin parasites | 3.82% | 6.87% | 3.13% | 6.97% |
| Anaesthetics, sedatives and pain killers | 6.73% | 5.75% | 3.00% | 7.78% |
| Heart disease | 0.61% | 0.42% | 0.65% | 0.65% |
| Gastro-intestinal problems | 1.38% | 0.56% | 0.26% | 0.65% |
| Fungal infections | 0.15% | - | 0.26% | 0.32% |
| Coccidial infections | - | 0.28% | 0.26% | - |
| Dietary supplements | 0.46% | 1.12% | 0.13% | 0.16% |
| Anti Obesity | 0.31% | - | 0.13% | - |
| Protozoal infections | - | 0.14% | - | |
| Respiratory problems | 0.46% | - | - | - |
| Immune system product | 0.15% | - | - | - |
| Topical infections | - | - | - | - |
Animal Species Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 44.0% | 42.9% | 47.4% | 43.3% |
| Cat | 31.9% | 28.8% | 33.4% | 35.9% |
| Cattle | 13.0% | 15.6% | 7.5% | 8.1% |
| Rabbit | 2.8% | 3.6% | 4.5% | 4.7% |
| Horse | 3.2% | 3.0% | 3.1% | 2.9% |
| Sheep | 2.5% | 3.3% | 1.7% | 2.4% |
| Others | 2.6% | 3.0% | 2.5% | 2.7% |
Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 28.2% | 29.2% | 41.1% | 29.0% |
| Cat | 23.1% | 16.0% | 25.1% | 30.0% |
| Cattle | 31.8% | 37.4% | 17.7% | 17.1% |
| Rabbit | 3.6% | 2.9% | 5.2% | 8.6% |
| Horse | 1.0% | 1.2% | 1.3% | 1.0% |
| Sheep | 6.2% | 7.8% | 43.9% | 6.7% |
| Others | 6.2% | 5.3% | 5.6% | 7.6% |
Non-Serious Report:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Dog | 53.1% | 51.2% | 51.2% | 51.2% |
| Cat | 37.0% | 36.5% | 38.6% | 39.1% |
| Cattle | 2.1% | 2.3% | 1.1% | 3.1% |
| Rabbit | 2.4% | 4.0% | 4.0% | 2.6% |
| Horse | 4.5% | 4.0% | 4.3% | 3.9% |
| Sheep | 0.3% | 0.5% | 0.3% | 0.0% |
| Others | 0.6% | 1.5% | 0.5% | 0.0% |
Animal Report by Product Type:
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Inactivated vaccine | 22.08% | 24.26% | 15.89% | 12.52% |
| Live vaccine | 12.83% | 13.84% | 15.40% | 16.07% |
| Pain and inflammation | 14.15% | 10.26% | 12.75% | 10.32% |
| Skin parasites | 5.09% | 77.78% | 10.93% | 7.11% |
| Inactivated and live vaccine | 10.75% | 11.04% | 10.10% | 11.17% |
| Bacterial infections | 7.55% | 6.69% | 5.46% | 8.63% |
| Hormone therapy product | 11.32% | 8.24% | 5.63% | 8.29 |
| Miscellaneous | 2.08% | 3.42% | 4.80% | 7.11% |
| Internal parasites | 3.96% | 4.67% | 5.46% | 2.71% |
| Internal and skin parasites | 3.58% | 3.89% | 5.63%% | 4.23% |
| Anaesthetics, sedatives and pain killers | 3.58% | 3.27% | 5.30% | 9.31% |
| Heart disease | 0.57% | 1.40% | 0.99% | 0.68% |
| Gastro-intestinal problems | 0.75% | 0.62% | 0.83% | 0.85% |
| Fungal infections | 0.19% | - | - | 0.34% |
| Coccidial infections | 0.19% | - | 0.17% | - |
| Dietary supplements | 0.57% | 0.31% | 0.33% | 0.51% |
| Anti Obesity | 0.57% | - | 0.33% | 0.17% |
| Protozoal infections | - | - | - | - |
| Respiratory problems | 0.19% | 0.16% | - | - |
| Immune system product | - | 0.16% | - | - |
| Topical infections | - | - | - | - |
Last Updated: 23 April 2012
